Vaccine Guidance

The staff of Arise Infusion encourages our patients to obtain the COVID-19 vaccine when it becomes available. Based on the data for the mRNA COVID-19 vaccines available in the U.S., there is no preference for one COVID-19 vaccine over another. We are not able to provide COVID-19 vaccine in our clinics.

If you were referred to ARISE Infusion by a physician external to ARA, please contact your referring provider for medication guidance prior to obtaining the COVID-19 vaccine.

We support the new (2/10/2021) guidance from the American College of Rheumatology regarding how to take various medications around the time of COVID-19 vaccinations that use mRNA (by Pfizer and Moderna):

If you take any of the following medications, and your rheumatologic disease is doing well, do not take this medication for 1 week after each dose of COVID-19 vaccine:

Methotrexate (Otrexup, Rasuvo, Rheumatrex)

Xeljanz (tofacitinib)

Rinvoq (upadacitinib)

Olumiant (baricitinib)

If you take the following medications, contact ARA when you are nearing the time of your COVID-19 vaccination to plan scheduling the doses:

Orencia (abatacept)

Rituxan (rituximab)

Cyclophosphamide intravenous only (Cytoxan)

If you take the following medications, you do not have to change your medication dosing schedule around the time of COVID-19 vaccination:

Reference link: American College of Rheumatology COVID-19 Vaccine Clinical Guidance Summary for Patients with Rheumatic and Musculoskeletal Diseases.